Related Experiment Video
Updated: Apr 29, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Less understood issues: p21(Cip1) in mitosis and its therapeutic potential
N-N Kreis1, F Louwen1, J Yuan1
1Department of Gynecology and Obstetrics, J.W. Goethe-University, Frankfurt, Germany.
Abstract:
p21(Cip1) is a multifunctional protein and a key player in regulating different cellular processes. The transcription of p21 is regulated by p53-dependent and -independent pathways. The expression of p21 is increased in response to various cellular stresses to arrest the cell cycle and ensure genomic stability. p21 has been shown to be a tumor suppressor and an oncogene as well. The function of p21 in mitosis has been proposed but not systematically studied. We have recently shown that p21 binds to and inhibits the activity of Cdk1/cyclin B1, and is important for a fine-tuned mitotic progression. Loss of p21 prolongs the duration of mitosis and results in severe mitotic defects like chromosome segregation and cytokinesis failures promoting consequently genomic instability. Moreover, p21 is dramatically stabilized in mitotic tumor cells upon treatment with mitotic agents like paclitaxel or mitotic kinase inhibitors. Increased p21 is mainly localized in the cytoplasm and associates with cell survival indicating a crucial role of p21 in susceptibility to mitotic agents in tumor cells. In this review we will briefly summarize the structure and general physiological functions as well as regulation of p21, discuss in detail its role in mitosis and its potential to serve as a therapeutic target.
Insights
The cell cycle regulator p21 (also known as Cip1) is crucial for mitosis. Loss of p21 causes mitotic defects and genomic instability, while its stabilization in tumor cells suggests a role in cancer therapy.
Area of Science:
- Cell Biology
- Molecular Oncology
Background:
- p21 (Cip1) is a key regulator of cellular processes, with dual roles as a tumor suppressor and oncogene.
- Its role in mitosis, though proposed, has not been systematically investigated.
- p21 expression is modulated by p53-dependent and -independent pathways in response to cellular stress.
Purpose of the Study:
- To systematically investigate the function of p21 in mitosis.
- To elucidate the role of p21 in mitotic progression and genomic stability.
- To explore the therapeutic potential of p21 in cancer treatment.
Main Methods:
- Biochemical assays to determine p21 binding and inhibition of Cdk1/cyclin B1 activity.
- Analysis of mitotic progression, chromosome segregation, and cytokinesis in cells with and without p21.
- Investigation of p21 stabilization and localization in mitotic tumor cells treated with mitotic agents.
Main Results:
- p21 binds to and inhibits Cdk1/cyclin B1, ensuring precise mitotic progression.
- Loss of p21 leads to prolonged mitosis, chromosome segregation errors, and cytokinesis failure, promoting genomic instability.
- p21 is stabilized in the cytoplasm of mitotic tumor cells treated with paclitaxel or mitotic kinase inhibitors, correlating with cell survival.
Conclusions:
- p21 plays a critical role in regulating mitosis and maintaining genomic stability.
- Stabilized p21 in tumor cells suggests its involvement in resistance to mitotic agents and potential as a therapeutic target.
More Related Videos
15:53Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Negative Regulator Molecules
Mitogens and the Cell Cycle